Dr Thomas Bachelot
- Specialty
- Oncologist, breast and gynecology expert
- Title
- Assistant department coordinator
- Hospital
- Centre Léon Bérard (Lyon)
- Latest articles
-
- Nivolumab in combination with ipilimumab versus capecitabine as post-operative treatment for triple negative breast cancer patients with residual disease after neoadjuvant chemotherapy: a multicentre, randomized, open-label phase II trial - BREASTIMMUNE-03. (Nov 21, 2025)
- Remotely supervised online cognitive training to reduce cognitive difficulties following chemotherapy in patients treated for localized breast cancer: Protocol of the Cog-Stim2 multicenter randomized controlled trial. (Nov 13, 2025)
- Erratum: Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay. (Nov 10, 2025)
- Machine Learning-Based Prediction of Distant Recurrence Risk and Ribociclib Treatment Effect in HR+/HER2- Early Breast Cancer Using Real-World and NATALEE Data. (Nov 10, 2025)
- Exceptional responses to Trastuzumab deruxtecan in HER2-positive breast cancer: two illustrative case reports. (Oct 22, 2025)